This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

Want to join our team?

AXIS Neuromonitoring is committed to providing quality healthcare with a “patient first” focus. AXIS technologists are continually trained at the highest level to provide neuromonitoring during complex surgical procedures involving the brain and nervous system, and they are supported with cutting-edge technology and processes. Use of IONM techniques in the O.R. have been shown to increase safety and help reduce morbidities without posing additional risks to patients. Positive outcomes help improve patient lives and reduce healthcare costs.

AXIS Neuromonitoring is always looking for experienced IOM technologists and support staff to join our team!

See Our Job Openings

Latest News

03.30.20
Surgical approach linked to risk in hip replacement

The researchers say that the anterior approach to hip arthroplasty is slightly more risky than the posterior or lateral approaches. "The small but statistically significant increase in the risk of major surgical complications associated with the anterior approach may help inform decisions for total hip arthroplasty," write Daniel Pincus, MD, PhD, of the Sunnybrook Health Sciences Center in Toronto, Canada, and his colleagues.

03.27.20
Minimally Invasive Artificial Disc Replacement Shows “Significantly Better Results” Compared to Traditional Procedures (Source: Minimally Invasive Neurosurgery of Texas)

Dr. Scott Kutz, an expert in the field of cervical spine surgery, has published a new article that discusses how minimally invasive spine surgery has shown “significantly better results” in terms of risks and recovery period than traditional open spine surgery.

03.23.20
NorthShore neurosurgeon first in Illinois to offer new targeted therapy for brain tumors

NorthShore University HealthSystem (NorthShore) neurosurgeon, Julian Bailes, MD, is the first in Illinois to begin offering GammaTile® Therapy, a new approach to treating malignant brain tumors. The FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) is designed to delay tumor regrowth for patients with high grade gliomas, meningiomas and brain metastases. The first patient in the state was treated by Dr. Bailes who is chairman of the department of neurosurgery and co-director of the NorthShore Neurological Institute. Neuro-oncologist Ryan Merrell, MD, will also be participating in this new surgical therapy at NorthShore.

All News